In CERS5 knock-out mice, the cellular C16:0 sphingolipid pool is decreased [37], and in our previous work, we showed that C16:0 ceramide was elevated in SLE compared to controls, normalized after immunosuppressive treatment, and that it was associated with higher disease activity [38]. Here, CERS5 is linked to systemic lupus erythematosus.